Search

Medicortex FInland Oy seeks investment to develop a rapid diagnostic test to detect concussions

Open share issue for a medical device development Medicortex Finland Oy is seeking investments for the development of a rapid diagnostic test to detect concussion and mild traumatic brain injury.


The open share issue will support the sample analysis of the latest clinical trial and promote the diagnostic kit development.


The investments will also pave the way towards an IPO – Medicortex has reached a point of maturity developing the prototype, and is ready to become public. Minimum investment is 3 200 € (500 shares, 6.4 € per share) Earlier funding: 2 M€ from angel investors, and a total of 1.5 M€ as grants. The current valuation of the company is 10.7 M€.


To receive the investor package, please call our office (+358 400 870 366) or send us an e-mail to medicortex@medicortex.fi.



More information about the share issue and subscription of shares is available on our website www.medicortex.fi/investors.


Medicortex Finland Oy

Itäinen Pitkäkatu 4 B, 20520 Turku, Finland


Investments always carry risks. Invest responsibly